Close Menu

Young Investigator Profile: Jonathan Karr

Model of the System

Fellow, Mount Sinai School of Medicine

Recommended by Eric Schadt, Mount Sinai School of Medicine

NEW YORK (GenomeWeb) – When Jonathan Karr was finishing college, systems biology was taking off and becoming popular. As a senior, he took a systems biology class and was hooked.

"I just really loved the course and the approach to biology — there was a sort of logical, mathematical, and physical way of thinking about biological systems to generate predictions," Karr told GenomeWeb. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.